ITERUM THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.55 USD | -1.90% |
|
-7.19% | -21.32% |
| 04-29 | Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem | CI |
| 03-28 | Transcript : Iterum Therapeutics plc, Q4 2023 Earnings Call, Mar 28, 2024 |
Chart calendar Iterum Therapeutics plc
b5c46eebcc4dfa7cfbd364.NRzmT-Otj1dDpKS1z3l9hoJen_0KJDMw9rrHDFjvSj0.d1Kvfo7n2zwP5_XBlS831dcc5q56dwFCrNWqbj2DIEpaUbwBluPDNgnK1w~e27b6059f0a195aecebdd42c7bdf853d
Upcoming events on Iterum Therapeutics plc
Past events on Iterum Therapeutics plc
| 2024-03-28 08:30 | Q4 2023 Earnings Call |
| 2024-03-28 07:00 | Q4 2023 Earnings Release |
| 2024-03-21 10:00 | Investor Meeting - H.C. Wainwright |
| 2024-01-30 10:00 | Annual General Meeting |
| 2024-01-30 08:30 | REASSURE Phase 3 Clinical Trial Results Call |
| 2023-11-14 08:30 | Q3 2023 Earnings Call |
| 2023-11-14 07:00 | Q3 2023 Earnings Release |
| 2023-10-14 12:15 | IDWeek Conference - Poster No:2569 |
| 2023-10-14 12:15 | IDWeek Conference - Poster No:2568 |
| 2023-10-14 12:15 | IDWeek Conference - Poster No: 2016 |
| 2023-09-12 00:00 | H.C. Wainwright Global Investment Conference |
| 2023-08-11 08:30 | Q2 2023 Earnings Call |
| 2023-08-11 07:00 | Q2 2023 Earnings Release |
| 2023-08-01 10:00 | Extraordinary Shareholders Meeting |
| 2023-06-16 11:00 | ASM Microbe Conference - AAR-Friday-417 |
| 2023-06-16 11:00 | ASM Microbe Conference - AAR-Friday-401 |
| 2023-06-16 11:00 | ASM Microbe Conference - AAR-Friday-410 |
| 2023-05-12 07:00 | Q1 2023 Earnings Release |
| 2023-05-03 10:00 | Annual General Meeting |
| 2023-04-16 | European Clinical Microbiology and Infectious Disease Congress - Uncomplicated Urinary Tract Infecti |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,04 0,07 -50.53% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,01 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -102 -105 3.17% | -32,0 -34,3 6.81% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -102 -105 2.47% | -32,1 -34,8 7.6% | -24,5 -24,2 -1.36% | -30,4 -36,5 16.66% | -47,5 -48,0 1.18% | -38,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -103 -106 2.74% | -51,3 -43,5 -17.8% | -90,9 -94,3 3.67% | -44,1 -54,1 18.45% | -37,8 -37,7 -0.09% | -38,8 |
|
Net income Million USD | Released Forecast Spread | -103 -106 2.69% | -52,0 -44,0 -18.26% | -91,6 -94,9 3.52% | -44,4 -54,4 18.27% | -38,4 -38,2 -0.39% | -38,9 |
|
EPS USD | Released Forecast Spread | -106 -109 2.07% | -32,5 -35,7 8.82% | -8,40 -8,55 1.75% | -3,63 -4,44 18.24% | -2,96 -2,96 -0.17% | -2,35 |
| Announcement Date | 12/03/20 | 12/03/21 | 28/03/22 | 16/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,83 -6,50 -5.06% | -7,37 -7,50 1.69% | -8,05 -11,0 26.82% | -7,03 -11,2 37.2% | -7,93 -14,0 43.39% | -8,53 -8,70 1.95% | -10,8 -9,20 -17.63% | -16,7 -11,5 -45.09% | -11,4 -12,0 4.74% | -10,0 | -9,78 | -9,27 | -9,02 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,01 -7,48 46.34% | -3,07 -8,68 64.58% | -6,39 -12,2 47.5% | -29,7 -12,2 -143.77% | -4,99 -15,0 66.68% | -9,77 -9,88 1.1% | -12,1 -10,4 -16.2% | -3,72 -11,9 68.71% | -12,2 -12,2 -0.27% | -10,2 | -9,96 | -9,46 | -9,21 |
|
Net income Million USD | Released Forecast Spread | -4,18 -7,53 44.43% | -3,50 -8,73 59.89% | -6,74 -12,2 44.91% | -29,1 -12,2 -138.11% | -5,09 -15,0 66.12% | -9,89 -9,93 0.36% | -12,2 -10,4 -17.44% | -3,88 -11,9 67.49% | -12,4 -12,2 -1.22% | -10,2 | -9,99 | -9,48 | -9,23 |
|
EPS USD | Released Forecast Spread | -0,30 -0,60 50% | -0,30 -0,75 60% | -0,60 -1,05 42.86% | -2,38 -1,00 -138% | -0,41 -1,22 66.39% | -0,78 -0,80 2.5% | -0,95 -0,80 -18.75% | -0,30 -0,91 67.03% | -0,94 -0,94 -0.53% | -0,73 | -0,58 | -0,55 | -0,53 |
| Announcement Date | 28/03/22 | 13/05/22 | 12/08/22 | 10/11/22 | 16/03/23 | 12/05/23 | 11/08/23 | 14/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Iterum Therapeutics plc
| 2024-05-02 16:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 08:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-02 06:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ITRM Stock
- Calendar Iterum Therapeutics plc
